Catalyst Wire Dossier Catalyst Wire Dossier

Cosmetic Cream for Atopic Skin (anti-relapse efficacy and tolerability study)

· NAOS Argentina S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cosmetic Cream for Atopic Skin (anti-relapse efficacy and tolerability study), covering 2025-03-25 to 2025-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin. [NA]

See pricing